The Second Annual Advanced Therapeutic Interventions to Optimize Diabetes Care symposium will highlight the latest concepts in the treatment of diabetes. The symposium will offer specialists and primary care providers an interactive venue where leading experts will discuss advanced diabetes care in a real-world setting. The course will be taught by nationally and internationally known experts who are actively involved in clinical trials and studies related to the management of diabetes. Physicians will be provided with the necessary context to integrate the relevant information into their practices to improve the quality of life for their affected patients.
This conference is designed for professionals in the field of endocrinology, diabetes, bariatric/metabolic surgery, cardiology, epidemiology, gastroenterology, internal medicine, family medicine, pharmacology, nutrition, basic science, public health, as well as allied health professionals, policy makers and scientists from pharmaceutical and medical device industries.
At the conclusion of this activity, participants should be better able to:
Recognize and implement the latest therapeutic options for diabetes management
Understand how to integrate the new diabetes management options into the care of patients with diabetes in a real-world setting including digital monitoring, oral agents that minimize adverse side effects, combination injectable agents, and initiating and advancing newer insulin agents
Accreditor Disclosure of Conflicts of Interest Policy: Commercial Support
This course is supported, in part, by educational grants from industry, in accordance with ACCME accreditation Standards for Commercial Support. Appropriate acknowledgment will be given to all supporters at the time of the educational activity.
In accordance with the ACCME Standards for Commercial Support, course directors, planning committees, faculty and all others in control of the educational content of the CME activity must disclose all relevant financial relationships with any commercial interest that they or their spouse/partner may have had within the past 12 months. If an individual refuses to disclose relevant financial relationships, they will be disqualified from being a part of the planning and implementation of this CME activity. Owners and/or employees of a commercial interest with business lines or products relating to the content of the CME activity will not be permitted to participate in the planning or execution of any accredited activity.
Athena Philis-Tsimikas, MD Corporate Vice President Scripps Whittier Diabetes Institute La Jolla, California
Dr. Philis-Tsimikas reports the following: Company: DexCom, Eli Lilly, Novo Nordisk, Sanofi, Voluntis What was Received: Payment to Organization, no personal reimbursement to advisor Role: Advisory Board
Company: DexCom, Elcelyx , Eli Lilly, Mylan, Novo Nordisk, Sanofi What was Received: Payment to Organization, no personal reimbursement to investigator Role: Research Investigator
Company: Ionis (Spouse) What was Received: Salary / Stock Role: Employee
Amy Chang, MD Endocrinologist Scripps Clinic Medical Group
Dr. Chang has nothing to disclose.
Tamara Finger, CNS Scripps Whittier Diabetes Institute
Ms. Finger, CNS, has nothing to disclose.
Matt Levine, MD Endocrinologist Scripps Clinic Medical Group
Dr. Levine reports the following: Company: Abbvie, AstraZeneca, Janssen What was Received: Honorarium Role: Speaker
Company: Boehringer Ingelheim What was Received: Publication support Role: Author
Company: Dexcom What was Received: Consultant fee Role: Consultant
Máire Robacker, RN, MSN, PHN, CDE Scripps Whittier Diabetes Institute
Ms. Robacker has nothing to disclose.
Scripps Conference Services & CME has nothing to disclose.
AMA PRA Category 1 Credit(s)TM
Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Scripps Health designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This activity is in compliance with California Assembly Bill 1195, which requires that all CME activities comprising a patient care element include curriculum addressing the topic of cultural and linguistic competency. The intent of this bill is to ensure that health care professionals are able to meet the cultural and linguistic concerns of a diverse patient population through effective and appropriate professional development. The planners, speakers and authors of this CME activity have been encouraged to address issues relevant in their topic area.
The information provided at this educational initiative is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.